Cargando…
Emerging regenerative medicine and tissue engineering strategies for Parkinson’s disease
Parkinson’s disease (PD) is the second most common progressive neurodegenerative disease, affecting 1–2% of people over 65. The classic motor symptoms of PD result from selective degeneration of dopaminergic neurons in the substantia nigra pars compacta (SNpc), resulting in a loss of their long axon...
Autores principales: | Harris, James P., Burrell, Justin C., Struzyna, Laura A., Chen, H. Isaac, Serruya, Mijail D., Wolf, John A., Duda, John E., Cullen, D. Kacy |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949278/ https://www.ncbi.nlm.nih.gov/pubmed/31934611 http://dx.doi.org/10.1038/s41531-019-0105-5 |
Ejemplares similares
-
Development of optically controlled “living electrodes” with long-projecting axon tracts for a synaptic brain-machine interface
por: Adewole, Dayo O., et al.
Publicado: (2021) -
Bioactive Neuroelectronic Interfaces
por: Adewole, Dayo O., et al.
Publicado: (2019) -
Axonal Tract Reconstruction Using a Tissue-Engineered Nigrostriatal Pathway in a Rat Model of Parkinson’s Disease
por: Struzyna, Laura A., et al.
Publicado: (2022) -
Neural Substrate Expansion for the Restoration of Brain Function
por: Chen, H. Isaac, et al.
Publicado: (2016) -
3433 Tissue Engineered Nigrostriatal Pathway as a Test-Bed for Evaluating Axonal Pathophysiology in Parkinson’s disease
por: Clark, Elisia, et al.
Publicado: (2019)